Endpoints News 生物医药· Lei Lei Wu·· 2026-10-08AI 评分55
Endeavor BioMedicines 称其 IPF 在研药物中期试验成功,并宣称可逆转疾病
Endeavor notches major mid-stage trial win, says IPF drug can reverse disease
AI 导读
Endeavor BioMedicines 称其在研的慢性肺部疾病(IPF)药物在一项中期临床试验中取得成功,并宣称该药具有逆转疾病的潜力。该表述来自公司方面,原文可见部分未给出具体疗效数据、样本量或试验设计细节。原文为付费内容,正文仅显示开头段落。
正文
Endeavor BioMedicines said its treatment for a chronic lung disease succeeded in a mid-stage test, claiming the drug had the potential …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news